TITLE

SAFETY AND FEASIBILITY OF TIROFIBAN IN ELECTIVE PCI OF COMPLEX CORONARY ARTERY DISEASE

PUB. DATE
October 2010
SOURCE
Heart;Oct2010 Supplement, pA102
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Safety and Feasibility of Tirofiban in Elective PCI of Complex Coronary Artery Disease" by Jia Dean and colleagues is presented.
ACCESSION #
66245721

 

Related Articles

  • Safety of tirofiban for patients with acute ischemic stroke in routine clinical practice. YUAN-QUN ZHU; YAN-JUN ZHANG; HAI-LIN RUAN; QING LIU; QIN ZHAN; QIONG LI // Experimental & Therapeutic Medicine;2015, Vol. 10 Issue 1, p169 

    The aim of the present study was to investigate the safety of tirofiban alone and in combination with various treatments in acute ischemic stroke (AIS). A total of 120 patients with AIS were included in the study, and these patients were divided into three treatment groups: Group A (tirofiban...

  • IC Eptifibatide Compared with IC Tirofiban In Patients With Acute Anterior STEMI Undergoing Primary PCI. Vinall, Phil // MD Conference Express;Oct2011, p14 

    The article focuses on the result of a study which compares the intracoronary (IC) eptifibatide and IC tirofiban for the treatment of acute anterior ST segment elevation myocardial infarction (STEMI) in patients undergoing primary percutaneous intracoronary intervention (PCI). The study was...

  • No adequate predictors to guide the treatment of post-TIA stroke.  // Modern Medicine;Nov94, Vol. 62 Issue 11, p63 

    Presents an abstract of an article entitled `Factors Affecting Survival and Occurrence of Stroke in Patients With Transient Ischemic Attacks,' by B.A. Evans, J.D. Sciks and J.P. Whisnant in the May 1994 issue of the `Mayo Clinical Proceedings,' about the lack of adequate predictors to guide the...

  • ...and, long term, it improves survival for those with heart disease.  // Modern Medicine;Feb95, Vol. 63 Issue 2, p46 

    Presents an abstract of the article `Randomized Trial of Cholesterol Lowering in 4,444 Patients with Coronary Heart Disease: The Scandinavian Simvastatin Survival Study (4s),' by the Scandinavian Simvastatin Survival Study Group from the periodical `The Lancet,' dated November 19, 1994.

  • Bypass is best for patients with serious coronary artery disease.  // Modern Medicine;Oct95, Vol. 63 Issue 10, p45 

    Presents an abstract of the article `Comparison of 15-year Survival for Men and Women After Initial Medical or Surgical Treatment for Coronary Artery Disease: A CASS Registry Study,' by K.B. Davis, B. Chaitman, T. Ryan, et al from the `Journal of the American College of Cardiology' dated April 1995.

  • Dalteparin is an alternative to heparin for patients with unstable CAD.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p54 

    Presents an abstract on the article `Low-Molecular-Weight Heparin During Instability in Coronary Artery Disease,' by the Fragmin During Instability in Coronary Artery Disease Study Group published in the March 2, 1996 issue of the `Lancet' journal.

  • Pravastatin halts course of atherosclerosis and MI in at-risk patients.  // Geriatrics;Apr96, Vol. 51 Issue 4, p63 

    Presents an abstract of the research report `Pravastatin Limitation of Antherosclerosis in the Coronary Arteries (PLAC 1): Reduction in Atherosclerosis Progression and Clinical Events,' by B. Pitt, G.B.J. Mancini, et al, as presented in a 1995 issue of the `Journal of the American College of...

  • Carvedilol has a beneficial effect on left ventricular remodeling.  // Geriatrics;June97, Vol. 52 Issue 6, p81 

    Presents an abstract of the work `Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease,' by R.N. Doughty, G.A. Whalley et al, from the `Journal of American College of Cardiology' dated April 1997. Properties of carvedilol;...

  • Combination of aspirin and warfarin reduces risk of reocclusion.  // Geriatrics;Jan98, Vol. 53 Issue 1, p75 

    Presents an abstract of the article `Progression of the Culprit Lesion in Unstable Coronary Artery Disease with Warfarin and Asprin Versus Asprin Alone,' by M.J.A. Williams, I.M. Morison, J.H. Parker and others, which was published in the August, 1997 issue of `J Am Coll Cardiol.'

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics